BDR Pharma to launch 400 mg Favipiravir tablets
The 400 mg tablets will be priced at Rs 990 for a strip of 10 tablets
BDR Pharmaceuticals said it plans to launch 400 mg Favipiravir tablets, used for treating COVID-19 patients, in the country.
The ”BDFAVI” 400 mg tablets will be priced at Rs 990 for a strip of 10 tablets, BDR Pharma said in a statement. Each tablet will cost Rs 99.
In August, the company launched 200 mg Favipiravir tablets.
“We aim to make BDFAVI available in sufficient quantities to meet the high demand for the drug in the Indian market to help curb the current crisis… introducing a higher dosage is an attempt to ensure a smoother experience to patients and caregivers,” said Dharmesh Shah, BDR Pharma, CMD.
The company had received approval from the Drugs Controller General of India (DCGI) to manufacture Favipiravir to treat patients with mild to moderate COVID-19 symptoms under the brand name BDFAVI, according to the statement.
- Advertisement -
FAVIPIRAVIR
They claim this is the medicine for COVID19.. WHO CERTIFIED THE MEDICINES? ANY GOVERNMENTAL
AGENCY HAS ANALLLISED THE OUT COME OF THE USAGE OF THIS MEDICINE? IF THIS FAVIPIRAVIR IS REALLY WORKING ON COVID 19, WHY SO MANY DEATHS ARE TAKING PLACE THROUGHOUT THE WORLD. WHY MANY AFFLUENT COUNTRIES LIKE U S, GERMANY, FRANCE, ETC ARE NOT USING THIS MEDICINE AND GET RID OF VIROUS?
IF THIS MEDICINE IS REQUIRED TO BE USED IN CERTAIN CONDITIONS OF THE PATIENT, THESE CONDITIONS SHOULD BE WELL BROUGHT OUT THROUGH MEDIA ETC. THOUGH THESE MEDICINES ARE TO BE SOLD THROUGH THE PRESCRIPTION OF A DOCTOR, IT IS A WELL KNOWN FACT OUR CHEMISTS WON’T FOLLOW STRICTLY. WHETHER GOVERNMENT HOSPITALS ARE USING THIS MEDICINES.? THERE ARE SO MANY DOUBTS IN THE MINDS OF THE PEOPLE ABOUT USINGTHE MEDICINE. THAT TOO, IT IS EXPENSIVE AT RS 99/- PER TAB TO INDIAN STANDARDS.
Blue Cross Laboratories is also launching Favipiravir 400 mg at Rs 64/- per tablet under the name FaviBlu. They already have 200 mg in the market at Rs 32/- per tablet which is most affordable in India.
Please let me know about Blue cross laboratories’s Favipiravir link.
What is the porpose of this tables in covid 19? By the way nice article